- pharma
Orthosiphon aristatus leaf
Concern score
Not assessed — no hazard data yet.
What we know about this ingredient
Orthosiphon aristatus leaf is in the Greenveil catalog but has not been assessed — "Not assessed" means we have no published hazard evidence for it yet, not that it is safe.
Regulation
No restrictions found. Orthosiphon aristatus leaf appears in these published regulatory listings.
- In marketed US drugs
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 3 active drug products and 3 total products.
- FDA NDC lists this ingredient in 3 active drug products and 3 total products.Source →
Evidence & sources
No graded research studies for Orthosiphon aristatus leaf yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Where this comes from
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
Where it has been recorded
How often FDA National Drug Code directory has listed Orthosiphon aristatus leaf in a product composition. These are source records, not Greenveil catalog products.
Source records
3
